AbbVie: Genmab dismisses Abbvie lawsuit - accused of exploiting trade secrets

Danish pharmaceutical company Genmab strongly denies the allegations made in a lawsuit filed by Abbvie in the US, accusing the company of exploiting trade secrets related to its drug candidate Rina-S and other ADC products. The dispute concerns techniques for using disaccharides to improve the water solubility of antibody drugs. Abbvie claims that former employees, who now work at ProfoundBio - a company Genmab acquired in 2024 - have passed on information. Genmab claims that Abbvie neither made patent claims nor developed products based on this information. The ongoing legal case does not affect Genmab's collaboration with Abbvie on epcoritamab, which continues as planned. No financial details are provided.